SAO PAULO, Nov 29 (Reuters) - Brazilian education holding company Anima Holding SA (ANIM3.SA) has reached an agreement to sell 25% of its medical education subsidiary Inspirali to health-focused investment fund DNA Capital for 1 billion reais ($179 million), it said in a Monday securities filing. Inspirali, according to Anima, is the second largest medical education company in Brazil, with close to 10,000 students spread across the country. The unit reported a net revenue of 436.6 million reais in the first nine months of 2021, Anima said. DNA Capital has investments in more than 20 firms, including DASA (DASA3.SA), a major medical diagnostics company in Brazil. The deal will need approval from Brazil"s competition watchdog, Cade, Anima said. ($1 = 5.60 reais)